The FDA has granted an in-person Type C meeting during the first quarter of 2026 New independent analyses across large observational ALS cohorts demonstrate that modest (~10%) NfL reductions are ...

The government is set to form the Narayanganj Development Authority (NDA) to develop the city and its adjoining areas into a ...

Takeda (TSE:4502/NYSE:TAK) and Protagonist Therapeutics (Nasdaq: PTGX) (“Protagonist”) announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking ...

Inhibrx Biosciences, Inc. stays a Strong Buy with Q2 2026 ozekibart BLA catalyst, 2026 PFS data, and Ewing sarcoma updates.

FDA accepted NDA for zidesamtinib for the treatment of TKI pre-treated patients with advanced ROS1-positive NSCLC; PDUFA target action date of September ...

Topline data from CHAPTER-3, a pivotal study of deucrictibant for prophylactic treatment of HAE attacks, anticipated in 3Q2026Preparation of NDA dossier of deucrictibant for on-demand treatment of HAE ...

This clinical-stage biotech specializing in blood disorders reported a notable insider sale amid strong recent stock performance.

The Enforcement Directorate (ED) has moved the Supreme Court, accusing West Bengal's Chief Minister of obstructing a central ...

The political conflict between the Enforcement Directorate (ED) and West Bengal's government escalates as the agency ...

Following these transactions, Broadwood Partners directly owns 15,426,144 shares of STAAR Surgical. Neal C. Bradsher, as President of Broadwood Capital Inc., the General Partner of Broadwood Partners, ...